- Home
- PLX vs GMGI Comparison
PLX vs GMGI Comparison
Compare PLX & GMGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLX
- GMGI
- Stock Information
- Founded
- PLX 1993
- GMGI 2008
- Country
- PLX United States
- GMGI United States
- Employees
- PLX N/A
- GMGI N/A
- Industry
- PLX Biotechnology: Biological Products (No Diagnostic Substances)
- GMGI Computer Software: Prepackaged Software
- Sector
- PLX Health Care
- GMGI Technology
- Exchange
- PLX Nasdaq
- GMGI Nasdaq
- Market Cap
- PLX 164.2M
- GMGI 142.5M
- IPO Year
- PLX 1998
- GMGI N/A
- Fundamental
- Price
- PLX $2.60
- GMGI $1.12
- Analyst Decision
- PLX Strong Buy
- GMGI Strong Buy
- Analyst Count
- PLX 1
- GMGI 1
- Target Price
- PLX $15.00
- GMGI $4.00
- AVG Volume (30 Days)
- PLX 792.6K
- GMGI 246.1K
- Earning Date
- PLX 11-13-2025
- GMGI 11-12-2025
- Dividend Yield
- PLX N/A
- GMGI N/A
- EPS Growth
- PLX N/A
- GMGI N/A
- EPS
- PLX 0.08
- GMGI N/A
- Revenue
- PLX $61,948,000.00
- GMGI $172,818,124.00
- Revenue This Year
- PLX $14.53
- GMGI $25.43
- Revenue Next Year
- PLX $75.77
- GMGI $13.00
- P/E Ratio
- PLX $33.57
- GMGI N/A
- Revenue Growth
- PLX 62.79
- GMGI 54.66
- 52 Week Low
- PLX $0.99
- GMGI $0.91
- 52 Week High
- PLX $3.10
- GMGI $3.06
- Technical
- Relative Strength Index (RSI)
- PLX 82.14
- GMGI 49.14
- Support Level
- PLX $1.52
- GMGI $1.06
- Resistance Level
- PLX $2.12
- GMGI $1.16
- Average True Range (ATR)
- PLX 0.12
- GMGI 0.08
- MACD
- PLX 0.05
- GMGI 0.02
- Stochastic Oscillator
- PLX 96.79
- GMGI 60.00
About PLX Protalix BioTherapeutics Inc. (DE)
Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis. The company's primary sources of revenue include its sales of BioManguinhos alfataliglicerase in Brazil and of drug substances to Pfizer under its Amended Pfizer Agreement. The company's pipeline consists of ELFABRIO, Uricase, and Long Acting DNase I.
About GMGI Golden Matrix Group Inc.
Golden Matrix Group Inc is an established gaming technology company. The company develops and owns online gaming IP and builds configurable and scalable white-label social gaming platforms for its international customers. The company operates in three reportable segments; MeridianBet Group, GMAG, RKings & CFAC. The MeridianBet Group segment earns majority revenue. The company operates in UK, Europe, Asia Pacific, Central and South America, Australia and Africa. It offers configurable and scalable iGaming platforms and operate some of the industry's iconic brands, including MexPlay, GM-AG, and others.